Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017106
University of Pennsylvania, Philadelphia, PA, United States
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Defining mechanisms of immunotherapy resistance in head and neck squamous cell carcinomas
Apo E Genotype and Hdl Changes with Exercise Training
Proteins Interacting with Dishevelled in Vertebrates
TIMED/CEDAR: Support for the Development of a Sequential Estimator for Global Wind Mapping
Large Scale Distributed Modeling and Parameter Estimation of Power Transformers
Recently added grants:
Iron as an Imaging Biomarker for Inflammation in AD
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
Impact of Aging on Mucosal Immune Protection in the Female Reproductive
Mechanisms of Gonococcal Pilin Antigenic and Phase Variation
Role of Staphylococcus aureus alpha-hemolysin in disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017106-002
Application #
6688655
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017106
/ University of Pennsylvania
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017106
/ University of Pennsylvania
Publications
Ruszczyk, Melanie; Zirpoli, Gary; Kumar, Shicha et al.
(2016)
Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
Cancer Causes Control 27:183-98
Comments
Be the first to comment on this grant